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9.3 PSYCHOSIS BIOTYPES VERSUS CLINICAL 
SYNDROMES THROUGH THE PRISM OF 
INTRINSIC NEURAL ACTIVITY
Brett Clementz*,1, Godfrey Pearlson2, Carol Tamminga3, 
John Sweeney3, Matcheri Keshavan4
1University of  Georgia; 2Olin Neuropsychiatry Research 
Center; 3University of  Texas Southwestern Medical Center; 
4Beth Israel Deaconess Medical Center & Harvard Medical 
School
Background: Deviation in level of  intrinsic neural activity (ongo-
ing brain signals recorded with EEG/MEG) is observed in psychosis. 
Neurophysiological models have proposed this physiological indicator 
as a genetically mediated core deviation in psychosis. Translational 
models of  intrinsic activity deviations promise to identifying multiple 
distinct physiological mechanisms for psychosis manifestation. Intrinsic 
activity deviations may masquerade as higher levels of  neural response 
in sensory cortices, but ultimately may lead to poor signal-to-noise 
ratios, particularly when psychosis cases are required to identify stim-
ulus salience.
Why do we not hear more about intrinsic activity as a core biomarker 
for any psychosis variation? An explanation is provided by the cur-
rent project. The Bipolar-Schizophrenia Network for Intermediate 
Phenotypes (B-SNIP) published a means for categorizing psychoses by 
neurobiological homology via use of  multiple biomarkers (psychosis 
Biotypes) rather than by clinical features. B-SNIP demonstrated the 
superiority of  Biotypes versus DSM diagnoses for capturing neurobio-
logical similarity through multiple external validating measures (social 
functioning, measures of  brain volume from structural magnetic res-
onance images, clinical diagnoses and biomarker features among 
first-degree relatives). Independent analyses since the initial publica-
tion have provided additional support for the usefulness of  psychosis 
Biotypes.
Methods: For this project, we analyzed ongoing neural activity from 
64 EEG sensors during 150 intervals of 10  sec duration from over 1450 
B-SNIP subjects. These data (never before published) were from the inter-
trial interval (ITI) of an auditory paired-stimuli task used in Biotypes con-
struction (these ITI data themselves were not used). Although the subjects 
were engaged in a task (counting the number of stimulus pairs), the data 
used here were not part of the task itself. Data were evaluated for single 
trial power (estimate of neural response strength on individual trials) as a 
function of frequency of neural oscillations (from 2–50 Hz) over the whole 
head. Data were then averaged over single trials to yield an estimate of 
the overall strength of nonspecific (unrelated to sensory processing) neural 
activity.
Results: When evaluated by DSM diagnoses (schizophrenia, schizoaffective 
disorder, bipolar disorder), the 95% confidence intervals for all groups over-
lapped the healthy group means across all frequencies. When considered by 
psychosis Biotypes, differences were obvious and statistically significant. In 
comparison to healthy persons, Biotype-2 probands (the most neurophysi-
ologically activated subgroup in previous analyses) were notably high on 
nonspecific neural activity, and Biotype-1 probands (the most cognitively 
and neurophysiologically compromised subgroup in previous analysis) 
were notably low. Group separations on this metric were better than those 
obtained with original intrinsic EEG measure used in psychosis Biotypes 
construction, indicating this more pure intrinsic activity measure is captur-
ing a meaningful component of Biotype neurophysiology. This was true 
across a range of oscillatory frequencies for the probands. The first-degree 
relatives of the Biotype probands showed similar patterns, although higher 
frequency oscillations (above 20 Hz) better differentiated relatives from 
healthy persons.
Discussion: Intrinsic activity deviation is a promising biomarker for transla-
tional research programs aimed at differential treatment development, but 
using DSM psychosis diagnoses would obscure its importance for under-
standing psychosis.
9.4 COMPLEX SYSTEM THEORY AND THE 
TRANSDIAGNOSTIC USE OF EARLY WARNING 
SIGNALS TO FORESEE THE TYPE OF FUTURE 
TRANSITIONS IN SYMPTOMS
Marieke Wichers*,1, Marieke Schreuder1, Catharina Hartman1, 
Hanneke Wigman1
1Interdisciplinary Center Psychopathology and Emotion regulation 
(ICPE), University Medical Center Groningen
Background: Recently, we showed that assumptions from complex system 
theory seem applicable in the field of psychiatry. This means that indicators of 
critical slowing down in the system signal the risk for a critical transition in the 
near future. In the current study we wanted to explore whether the principle 
of critical slowing down may also be informative to anticipate on the type of 
symptoms that individuals are most likely to develop. This is relevant as it 
may lead to personalized prediction of risk of whether adolescents with mixed 
complaints are most likely to develop either depression, anxiety, somatic or 
psychotic symptoms in the near future. For example, we hypothesized that 
critical slowing down in feeling ‘suspicious’ more strongly indicates risk for a 
future transition to psychotic symptoms, while critical slowing down in feeling 
‘down’ more strongly indicates risk for a transition to depressive symptoms.
Methods: We examined this in a population of adolescents (most between 15 
and 18 years) as adolescents are an at-risk group for the development of psy-
chopathology. At baseline experience sampling was performed for 6 days, 10 
measurements a day. Affect items were used to assess autocorrelation as an 
indicator of ‘critical slowing down’ of the system. At baseline and follow-up 
SCL-90 questionnaires were administered. In total, 147 adolescents partici-
pated both in baseline and follow-up measures and showed increases in at 
least one of the defined symptom dimensions. We examined whether auto-
correlation was positively associated with the size of symptom transition 
and whether different type of transitions (in depression, anxiety etc.) were 
differentially predicted by autocorrelations in specific affect states.
Results: The analyses were done very recently, and findings have not been 
presented before. We found both shared and specific indicators of  risk 
in the development for transition to various symptom dimensions. First, 
autocorrelation in ‘feeling suspicious’ appeared to be the strongest sig-
nal for all assessed psychopathology dimensions (SCL-90 depression: std 
beta: 0.185; p <0.001; SCL-90 anxiety: std beta: 0.093; p=0.006; SCL-90 
interpersonal sensitivity: std beta: 0.176, p<0.001). Second, we found that 
the combination of  ‘feeling suspicious’ and the affect with the second-
highest autocorrelation together predicted the precise type of  symptom 
transition. Thus, the combination of  feeling suspicious (std beta: 0.185; 
p<0.001) and down (std beta: 0.108; p=0.001) predicted larger increases 
in depressive symptoms one year later on the SCL-90, while the combina-
tion of  feeling suspicious (std beta: 0.093; p=0.006) with feeling anxious 
(std beta: 0.086; p=0.014) predicted larger increases in anxiety symptoms 
a year later on the SCL-90.
Discussion: These findings support the hypothesis that indicators of slowing 
down can not only be used to predict risk for a mean level shift in symptoms, 
but that they can also be informative for the type of symptom transitions at 
hand. In a next step these findings could be translated to designs measuring 
personalized early warnings for future direction of symptom shifts, and if  
successful to clinical implementation of these techniques.
10. THE MOLECULAR MECHANISMS OF 
SCHIZOPHRENIA FROM GLIAL CELLS 
PERSPECTIVE
Sabina Berretta1
1Harvard Medical School, McLean Hospital
Overall Abstract: In the past decade, rapid advances in the field of neurosci-
ence resulted in a dramatic paradigm shift in the way we understand the role 
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of glia in normal brain functions and brain disorder pathology. A growing 
body of evidence shows that diversified populations of astrocytes, microg-
lia, oligodendrocyte precursors and mature oligodendrocytes play a critical 
role in the regulation of synaptic functions, blood-brain barrier, immune 
response regulation, myelination and axonal conduction, and in the synthe-
sis of the extracellular matrix, a key regulator of neural plasticity. Building 
on this evidence, exciting new findings are beginning to emerge, shedding 
light on glia abnormalities in schizophrenia and their impact these func-
tions. This symposium aims to discuss and integrate the current state of 
knowledge on direct evidence for glial abnormalities in schizophrenia and 
their underlying mechanisms.
Dr. Juliana Nascimiento will present novel findings on the effects of 
NMDAr antagonists and antipsychotics influence glial cell lines and 3D 
cultures as neurospheres and cerebral organoids. Results from these stud-
ies point to the central role of glycolysis, EIF2 signaling and translational 
machinery in oligodendrocytes and astrocytes. Dr. Paul Klauser will report 
on elegant investigations on the implication of developmental redox imbal-
ance inducing oxidative stress leading to impairments of oligodendrocytes, 
myelin formation and eventually to the disruption of white fibers integrity 
and conductivity, especially in brain regions where the metabolic demand 
is high. In patients, alterations of white matter were found to be inversely 
correlated with blood levels of GSH precursor cysteine and could be pre-
vented by the early administration of the antioxidant N-acetyl cysteine. Dr. 
Sabina Berretta will discuss recent findings on novel modalities of inter-
action between glial cells, extracellular matrix and neurons, postulated to 
affect synaptic structural plasticity and axonal conductance. A  growing 
body of evidence from her group shows disruption of such interactions in 
schizophrenia, potentially contributing to synaptic pathology and impact-
ing neural connectivity. Dr. Dost Ongur will build on previous work show-
ing abnormal diffusion of neuron-specific metabolite NAA in frontal white 
matter in patients with chronic schizophrenia in the absence of abnormali-
ties in the diffusion of non-specific metabolites Cr and Cho. State-of-the-
art recent studies on first episode psychosis patients and matched healthy 
controls show that NAA diffusion is normal in first episode patients but Cr 
and Cho diffusion is abnormal, suggesting that white matter abnormalities 
in non-neuronal elements in early phases of schizophrenia which are fol-
lowed by neuronal damage in chronic disease.
10.1 STEM CELL-DERIVED IN VITRO MODELS 
FOR DEPICTING THE ROLE OF GLIA IN 
SCHIZOPHRENIA FROM A PROTEOMIC 
PERSPECTIVE
Juliana Nascimento*,1, Daniel Martins-De-Souza1,  
Veronica M. Saia-Cereda1, Flavia C. A. Gomes2,  
Stevens K. Rehen3
1University of Campinas; 2Federal University of Rio de Janeiro; 
3Instituto D’Or de Pesquisa e Ensino (IDOR) and Federal 
University of Rio de Janeiro
Background: A number of basic and translational studies have clearly indi-
cated the vital role of glia in brain function and the pathophysiological 
mechanisms of neuropsychiatric disorders, including schizophrenia. The 
difficulty on studying the molecular basis of glial cells in vivo, led to the 
development of animal models, which are considered the gold standard to 
this type of understanding. However, the inherent difficulties in establishing 
these models for psychiatric disorders and the simplicity of in vitro models, 
especially given the recent advances in stem cell-based technologies have 
driven the development of sophisticated in vitro models, which may be 
attractive for studying the molecular basis of schizophrenia.
Methods: Here, we report our investigations in terms of proteome while 
establishing protocols to generate human pluripotent stem cells-derived 
cerebral organoids as well as human cerebral organoids-derived astrocytes 
and oligodendrocytes.
Results: The proteome of cerebral organoids show major proteins from 
neuronal cells as expected, but also several glial markers, supporting the 
notion that glial cells may be obtained out of these organoids. Besides, the 
proteome of three schizophrenia and three control organoids have been 
investigated. Proteins found are broadly distributed on functional activi-
ties such as cell growth and maintenance, energy metabolism and cell com-
munication and signaling, and are correlated to cortical brain tissue. We 
also succeeded in isolating astrocytes out of cerebral organoids. These 
cells are under investigation in terms of molecular differences associated 
to schizophrenia.
Discussion: The generation of brain organoids and isolation of astrocytes 
and eventually oligodendrocytes hold great potential for the investigation 
of the role of glia in schizophrenia, providing an useful approach to drug 
screening and disease modeling, as our results showed in schizophrenia- 
and control-derived cells. Additionally, proteomics adds knowledge about 
information and connections being formed into these models.
10.2 REDOX DYSREGULATION, 
OLIGODENDROCYTES AND WHITE MATTER 
ALTERATIONS IN SCHIZOPHRENIA
Paul Klauser*,1, Philipp S. Baumann1, Margot Fournier2, 
Lijing Xin3, Alessandra Griffa1, Martine Cleusix2, Raoul Jenni2, 
Michel Cuenod2, Patric Hagmann4, Philippe Conus1, Kim Q. Do2
1Lausanne University Hospital; 2Center for Psychiatric 
Neuroscience, Lausanne University Hospital; 3Animal Imaging and 
Technology Core (AIT), Center for Biomedical Imaging (CIBM), 
Ecole Polytechnique Fédérale de Lausanne; 4Signal Processing 
Laboratory, Ecole Polytechnique Fédérale de Lausanne, Lausanne 
University Hospital
Background: Widespread (Klauser et  al., 2016)  and progressive (Cropley 
et  al., 2017)  cerebral anomalies of white matter diffusion properties 
(i.e. fractional anisotropy, FA) have been observed in the Australian 
Schizophrenia Research Bank (ASRB), one of the largest samples of 
patients with schizophrenia. From a topological perspective, widespread 
alterations of white matter tend to concentrate into hub regions that inter-
connect brain areas over long-distances in a so-called “rich-club” (van den 
Heuvel et al., 2013; Klauser et al., 2016)  in which the metabolic demand 
is high and thus are most likely to suffer from oxidative stress. Evidence 
from human and animal models suggests that redox dysregulation leading 
to oxidative stress during neurodevelopment is implicated in schizophrenia 
pathogenesis (Steullet et al., 2017). At the cellular level, the triad composed 
of NMDAR hypofunction, neuroinflammation and dopamine dysregula-
tion interacts with redox imbalance and leads to oxidative stress, affecting 
oligodendrocytes precursor cells (OPC) and parvalbumine interneurons 
(Steullet et al., 2016). However, the links between redox imbalance, oligo-
dendrocytes and gross alterations of white matter integrity are largely unex-
plored. Under oxidative stress induced in vitro by impairing the synthesis 
of glutathione (GSH), the key player in antioxidant defense, OPC showed a 
decreased proliferation mediated by an upregulation of Fyn kinase activity. 
In the prefrontal cortex of a mouse model with impaired GSH synthesis, 
mature oligodendrocyte numbers as well as myelin markers were decreased 
at peripuberty (Monin et al., 2014). FA was also reduced in fornix-fimbria 
and anterior commissure, a change accompanied by a reduced conduction 
velocity (Corcoba et al., 2015).
Methods: 49 patients with psychosis and 64 healthy controls were scanned 
with the same 3-Tesla scanner. The diffusion spectrum imaging (DSI) 
sequence included 128 diffusion-weighted images with a maximum b-value 
of 8000 s mm−2. White matter diffusion properties were estimated using 
generalized fractional anisotropy (gFA). Total blood cysteine (Cys, protein-
bound form, free reduced and free oxidized form), the rate-limiting precur-
sor of GSH, was measured by high performance liquid chromatography 
from plasma samples collected at the same time-point as MRI brain scans. 
